AngioDynamics Port Catheter Lawsuit Update
AngioDynamics Port Catheter Lawsuit Update: Several AngioDynamics Port Catheter Lawsuits are consolidated into MDL No. 3125 in the Southern District of California before Judge Jinsook Ohta.
Current Litigation Status
- Case Count: Around 407 lawsuits are pending in the multidistrict litigation against AngioDynamics and its subsidiary, Navilyst Medical.
- Bellwether Trials: Both sides finalized an initial pool of 18 representative cases (9 chosen by plaintiffs and 9 by defendants) for case-specific discovery
- Settlements and Trials: There are no current jury verdicts or global settlements. Early bellwether test trials are anticipated to begin between late 2026 and 2028.
Allegations and Defects
- The Core Issue: Lawsuits claim that devices like the SmartPort, Vortex, and Xcela lines contain a defective mix of polyurethane and barium sulfate.
- Degradation: Plaintiffs argue the material degrades over time, causing catheters to crack, fracture, or migrate inside the body.
- Infection Risks: Recent AngioDynamics Port Catheter Lawsuits highlight severe bacterial colonization, biofilm accumulation, sepsis, and severe blood clots requiring surgical device removal.

